Ratko TA, Douglas GW, De Souza JA, Belinson SE, Aronson N. Radiotherapy treatments for head and neck cancer update. 2019.
Lu S, Fan H, Hu X, Li X, Kuang Y, Yu D, Yang S. Dosimetric comparison of helical tomotherapy, volume-modulated Arc therapy, and fixed-field intensity-modulated radiation therapy in locally advanced nasopharyngeal carcinoma. Front Oncol. 2021;11:764946.
PubMed PubMed Central Google Scholar
Ghosh A, Gupta S, Johny D, Vidyadhar Bhosale V, Pal Singh Negi M. A study to assess the dosimetric impact of the anatomical changes occurring in the Parotid glands and tumour volume during intensity modulated radiotherapy using simultaneous integrated boost (IMRT-SIB) in head and neck squamous cell cancers. Cancer Med. 2021;10(15):5175–90.
PubMed PubMed Central Google Scholar
Huang H, Lu H, Feng G, Jiang H, Chen J, Cheng J, Pang Q, Lu Z, Gu J, Peng L, Deng S. Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy. Radiat Oncol. 2015;10:1–9.
Fung WW, Wu VW, Teo PM. Developing an adaptive radiation therapy strategy for nasopharyngeal carcinoma. J Radiat Res. 2014;55(2):293–304.
Lu J, Ma Y, Chen J, Wang L, Zhang G, Zhao M, Yin Y. Assessment of anatomical and dosimetric changes by a deformable registration method during the course of intensity-modulated radiotherapy for nasopharyngeal carcinoma. J Radiat Res. 2014;55(1):97–104.
Bak B, Skrobala A, Adamska A, Kazmierska J, Jozefacka N, Piotrowski T, Malicki J. Criteria for verification and replanning based on the adaptive radiotherapy protocol best for adaptive radiotherapy in head and neck cancer. Life. 2022;12(5):722.
PubMed PubMed Central Google Scholar
Zhao L, Wan Q, Zhou Y, Deng X, Xie C, Wu S. The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma. Radiother Oncol. 2011;98(1):23–7.
Vanderstraeten B, Berwouts D, Goddeeris B, Duprez F, De Neve W, Lievens Y. Adaptive intensity-modulated radiation therapy for head and neck cancer: is it affordable? Int J Radiat Oncol Biol Phys. 2014;90(1):S107–8.
Chetty IJ, Cai B, Chuong MD, Dawes SL, Hall WA, Helms AR, Kirby S, Laugeman E, Mierzwa M, Pursley J, Ray X. Quality and safety considerations for adaptive radiation therapy: an ASTRO white paper: ASTRO ART safety white paper. Int J Radiation Oncology* Biology* Phys. 2024 Oct 16.
Ahn PH, Chen CC, Ahn AI, Hong L, Scripes PG, Shen J, Lee CC, Miller E, Kalnicki S, Garg MK. Adaptive planning in intensity-modulated radiation therapy for head and neck cancers: single-institution experience and clinical implications. Int J Radiation Oncology* Biology* Phys. 2011;80(3):677–85.
Cheng HC, Wu VW, Ngan RK, Tang KW, Chan CC, Wong KH, Au SK, Kwong DL. A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients. Radiother Oncol. 2012;104(3):317–23.
Yao W, Hu J, Xu P, He M, Fang Y, Liu M, Li Z, He H, Liu H, Sun W, Xu S. Accumulated dose deviation of rotational and residual setup errors on nasopharyngeal carcinoma using MIM treated by helical tomotherapy. Technol Cancer Res Treat. 2023;22:15330338231169601.
CAS PubMed PubMed Central Google Scholar
American Association of Physicists in Medicine. Standardizing nomenclatures in radiation oncology [Internet]. 2019.
User Guide of mim for use. with Accuray® PreciseART™ and PreciseRTX™, MIM 6.5.100, 2017 MIM Software Inc., TD-383 01-27-2017.
Thongsuk W, Nobnop W, Chitapanarux I, Wanwilairat S. Evaluation of daily dose accumulation with deformable image registration method using helical tomotherapy images for nasopharyngeal carcinoma. I Radiother Pract. 2021;20(3):273–8.
Kadoya N, Nakajima Y, Saito M, Miyabe Y, Kurooka M, Kito S, Fujita Y, Sasaki M, Arai K, Tani K, Yagi M. Multi-institutional validation study of commercially available deformable image registration software for thoracic images. Int J Radiation Oncology* Biology* Phys. 2016;96(2):422–31.
Calusi S, Labanca G, Zani M, Casati M, Marrazzo L, Noferini L, Talamonti C, Fusi F, Desideri I, Bonomo P, Livi L. A multiparametric method to assess the MIM deformable image registration algorithm. J Appl Clin Med Phys. 2019;20(4):75–82.
PubMed PubMed Central Google Scholar
Wang RH, Zhang SX, Zhou LH, Zhang GQ, Yu H, Lin XD, Lin S. Volume and dosimetric variations during two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma. Biomed Mater Eng. 2014;24(1):1217–25.
Beetz I, Van Der Schilstra C, Doornaert P, Van Luijk P, van der Vissink A, Leemans CR, Bijl HP, Christianen ME. NTCP models for patient-rated Xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors. Radiother Oncol. 2012;105(1):101–6.
Marzi S, Pinnaro P, D’Alessio D, Strigari L, Bruzzaniti V, Giordano C, Giovinazzo G, Marucci L. Anatomical and dose changes of gross tumour volume and Parotid glands for head and neck cancer patients during intensity-modulated radiotherapy: effect on the probability of Xerostomia incidence. Clin Oncol. 2012;24(3):e54–62.
Castelli J, Simon A, Louvel G, Henry O, Chajon E, Nassef M, Haigron P, Cazoulat G, Ospina JD, Jegoux F, Benezery K. Impact of head and neck cancer adaptive radiotherapy to spare the Parotid glands and decrease the risk of Xerostomia. Radiat Oncol. 2015;10:1–0.
Buciuman N, Marcu LG. Adaptive radiotherapy in head and neck cancer using volumetric modulated Arc therapy. J Personalized Med. 2022;12(5):668.
Bhide SA, Davies M, Burke K, McNair HA, Hansen V, Barbachano Y, El-Hariry IA, Newbold K, Harrington KJ, Nutting CM. Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study. Int J Radiation Oncology* Biology* Phys. 2010;76(5):1360–8.
Ho KF, Marchant T, Moore C, Webster G, Rowbottom C, Penington H, Lee L, Yap B, Sykes A, Slevin N. Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy. Int J Radiation Oncology* Biology* Phys. 2012;82(3):e375–82.
Thomson DJ, Beasley WJ, Garcez K, Lee LW, Sykes AJ, Rowbottom CG, Slevin NJ. Relative plan robustness of step-and-shoot vs rotational intensity–modulated radiotherapy on repeat computed tomographic simulation for weight loss in head and neck cancer. Med Dosim. 2016;41(2):154–8.
Wu Q, Chi Y, Chen PY, Krauss DJ, Yan D, Martinez A. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiation Oncology* Biology* Phys. 2009;75(3):924–32.
Lee C, Langen KM, Lu W, Haimerl J, Schnarr E, Ruchala KJ, Olivera GH, Meeks SL, Kupelian PA, Shellenberger TD, Mañon RR. Assessment of Parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration. Int J Radiation Oncology* Biology* Phys. 2008;71(5):1563–71.
Jensen AD, Nill S, Huber PE, Bendl R, Debus J, Münter MW. A clinical concept for interfractional adaptive radiation therapy in the treatment of head and neck cancer. Int J Radiation Oncology* Biology* Phys. 2012;82(2):590–6.
Fung WW, Wu VW, Teo PM. Dosimetric evaluation of a three-phase adaptive radiotherapy for nasopharyngeal carcinoma using helical tomotherapy. Med Dosim. 2012;37(1):92–7.
Franzese C, Tomatis S, Bianchi SP, Pelizzoli M, Teriaca MA, Badalamenti M, Comito T, Clerici E, Franceschini D, Navarria P, Di Cristina L. Adaptive volumetric-modulated Arc radiation therapy for head and neck cancer: evaluation of benefit on target coverage and sparing of organs at risk. Curr Oncol. 2023;30(3):3344–54.
PubMed PubMed Central Google Scholar
Jin X, Han C, Zhou Y, Yi J, Yan H, Xie C. A modified VMAT adaptive radiotherapy for nasopharyngeal cancer patients based on CT-CT image fusion. Radiat Oncol. 2013;8:1–8.
Hu YC, Tsai KW, Lee CC, Peng NJ, Chien JC, Tseng HH, Chen PC, Lin JC, Liu WS. Which nasopharyngeal cancer patients need adaptive radiotherapy? BMC Cancer. 2018;18:1–8.
Castelli J, Simon A, Rigaud B, Lafond C, Chajon E, Ospina JD, Haigron P, Laguerre B, Loubière AR, Benezery K, De Crevoisier R. A nomogram to predict Parotid gland overdose in head and neck IMRT. Radiat Oncol. 2016;11:1–1.
Brown E, Owen R, Harden F, Mengersen K, Oestreich K, Houghton W, Poulsen M, Harris S, Lin C, Porceddu S. Predicting the need for adaptive radiotherapy in head and neck cancer. Radiother Oncol. 2015;116(1):57–63.
Surucu M, Shah KK, Mescioglu I, Roeske JC, Small W Jr, Choi M, Emami B. Decision trees predicting tumor shrinkage for head and neck cancer: implications for adaptive radiotherapy. Technol Cancer Res Treat. 2016;15(1):139–45.
Morgan HE, Sher DJ. Adaptive radiotherapy for head and neck cancer. Cancers Head Neck. 2020;5:1–6.
PubMed PubMed Central Google Scholar
Gros SA, Santhanam AP, Block AM, Emami B, Lee BH, Joyce C. Retrospective clinical evaluation of a decision-support software for adaptive radiotherapy of head and neck cancer patients. Front Oncol. 2022;12:777793.
Comments (0)